Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade
-
Published:2022-07-29
Issue:1
Volume:13
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Kaur GurmanORCID, Porter Caroline B. M., Ashenberg Orr, Lee Jack, Riesenfeld Samantha J.ORCID, Hofree MatanORCID, Aggelakopoulou Maria, Subramanian AyshwaryaORCID, Kuttikkatte Subita Balaram, Attfield Kathrine E.ORCID, Desel Christiane A. E.ORCID, Davies Jessica L.ORCID, Evans Hayley G., Avraham-Davidi InbalORCID, Nguyen Lan T., Dionne Danielle A., Neumann Anna E.ORCID, Jensen Lise Torp, Barber Thomas R., Soilleux ElizabethORCID, Carrington MaryORCID, McVean GilORCID, Rozenblatt-Rosen OritORCID, Regev Aviv, Fugger LarsORCID
Abstract
AbstractFetal growth restriction (FGR) affects 5–10% of pregnancies, and can have serious consequences for both mother and child. Prevention and treatment are limited because FGR pathogenesis is poorly understood. Genetic studies implicateKIRandHLAgenes in FGR, however, linkage disequilibrium, genetic influence from both parents, and challenges with investigating human pregnancies make the risk alleles and their functional effects difficult to map. Here, we demonstrate that the interaction between the maternal KIR2DL1, expressed on uterine natural killer (NK) cells, and the paternally inherited HLA-C*0501, expressed on fetal trophoblast cells, leads to FGR in a humanized mouse model. We show that the KIR2DL1 and C*0501 interaction leads to pathogenic uterine arterial remodeling and modulation of uterine NK cell function. This initial effect cascades to altered transcriptional expression and intercellular communication at the maternal-fetal interface. These findings provide mechanistic insight into specific FGR risk alleles, and provide avenues of prevention and treatment.
Funder
Wellcome Trust RCUK | Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference162 articles.
1. de Onis, M., Blossner, M. & Villar, J. Levels and patterns of intrauterine growth retardation in developing countries. Eur. J. Clin. Nutr. 52, S5–S15 (1998). 2. Romo, A., Carceller, R. & Tobajas, J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr. Endocrinol. Rev. 6, 332–336 (2009). 3. Imdad, A. & Bhutta, Z. A. Nutritional management of the low birth weight/preterm infant in community settings: a perspective from the developing world. J. Pediatr. 162, S107–S114 (2013). 4. Bernstein, I. M., Horbar, J. D., Badger, G. J., Ohlsson, A. & Golan, A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Vt. Oxf. Netw. Am. J. Obstet. Gynecol. 182, 198–206 (2000). 5. Rosenberg, A. The IUGR newborn. Semin. Perinatol. 32, 219–224 (2008).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|